Alterity Therapeutics Limited (ATHE) Balance Sheet

NASDAQ: ATHEAssets, liabilities, debt and equity over 10 years.

ATHE balance sheet, FY2026

June 30, 2026 · Australian dollars

A$46.0M assets = A$3.3M liabilities + A$42.7M equity

What it ownsA$46.0MCash & ST investments: A$37.3M (81.1%)Cash & ST investmentsA$37.3M · 81%Receivables: A$7.7M (16.7%)ReceivablesA$7.7M · 17%Other current: A$811,828 (1.8%)PP&E: A$190,570 (0.4%)Other non-current: A$3 (0.0%)=How it is financedA$46.0MCurrent liabilities: A$3.2M (6.9%)Current liabilities A$3.2MOther LT liabilities: A$138,297 (0.3%)Shareholders’ equity: A$42.7M (92.8%)Shareholders’ equityA$42.7M · 93%

Both columns are drawn to the same scale: what ATHE owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ATHE financial health

Debt / equity0.00
Low leverage · A$0.00 of debt for each $1 of equity
Equity / assets92.8%
Equity-funded · of assets funded by shareholders
Cash / debt19,289.4%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal FY2026.

ATHE balance sheet trends, FY2017–FY2026

Alterity Therapeutics Limited balance sheet trends
MetricTrendThenLatestChange
Total assetsA$25.3MFY2017A$46.0MFY2026+6.9%/yr
Total liabilitiesA$1.6MFY2017A$3.3MFY2026+8.4%/yr
Shareholders’ equityA$23.7MFY2017A$42.7MFY2026+6.8%/yr
Cash & short-term investmentsA$21.9MFY2017A$37.3MFY2026+6.1%/yr
Total debtA$0FY2017A$193,475FY2026—
Net cash (debt)A$21.9MFY2017A$37.1MFY2026+A$15.2M
Working capitalA$23.7MFY2017A$42.7MFY2026+A$19.0M
Debt / equity0.00FY20170.00FY20260.00
Shares outstanding890KFY201717.5MFY2026+39.3%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ATHE assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ATHE liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ATHE debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ATHE balance sheet in Australian dollars

Alterity Therapeutics Limited annual balance sheet
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Assets
Cash & short-term investmentsA$37.3MA$40.7MA$12.6MA$15.8MA$34.8MA$28.1MA$9.2MA$14.4MA$15.2MA$21.9M
Cash & equivalentsA$37.3MA$33.2MA$12.6MA$15.8MA$34.8MA$28.1MA$9.2MA$14.4MA$15.2MA$21.9M
Short-term investments—A$7.5MA$0————A$0A$9,514A$43,988
ReceivablesA$7.7MA$3.9MA$4.0MA$8.6MA$4.7MA$4.1MA$61,321A$4.8MA$3.2MA$3.0M
InventoryA$0A$0−A$22,389A$2.6MA$1.6MA$2A$567,884A$621,737A$256,821A$241,625
Other current assetsA$811,828A$1.3MA$2.4MA$56,604A$66,188A$1.2MA$3.4MA$10,032A$290A$43,988
Total current assetsA$45.8MA$45.9MA$19.0MA$27.0MA$41.1MA$33.5MA$13.2MA$19.9MA$18.7MA$25.3M
Property, plant & equipment (net)A$190,570A$155,174A$186,883A$268,863A$218,522A$96,808A$71,369A$48,748A$71,422A$30,815
Goodwill & intangible assetsA$0A$0A$0A$0A$0A$0A$7.2MA$0A$0A$0
Long-term investmentsA$0A$0A$0A$0A$0A$0A$0A$0A$0A$0
Other non-current assetsA$3A$0A$0A$0A$0A$0A$0A$0A$0A$0
Total assetsA$46.0MA$46.0MA$19.2MA$27.3MA$41.4MA$33.6MA$13.3MA$19.9MA$18.7MA$25.3M
Liabilities
Accounts payableA$1.1MA$538,276A$581,137A$1.7MA$2.6MA$1.4MA$954,033A$1.7MA$1.3MA$65,049
Short-term debtA$55,177A$66,912A$107,131A$107,177A$57,632A$27,746A$32,879A$0A$0A$0
Deferred revenue——A$15,995−A$107,177−A$57,632−A$27,746−A$32,879———
Total current liabilitiesA$3.2MA$3.5MA$5.4MA$4.4MA$5.8MA$3.1MA$2.7MA$3.3MA$2.6MA$1.6M
Long-term debtA$0A$0A$0A$0A$0A$0A$0A$0A$0A$0
Lease obligationsA$193,465A$155,457A$159,045A$210,384A$117,489A$65,649A$33,747A$0A$0A$0
Other long-term liabilitiesA$138,297A$88,545A$51,914A$122,709A$73,610A$47,670A$42,382A$34,976A$916A$440
Total liabilitiesA$3.3MA$3.6MA$5.4MA$4.5MA$5.9MA$3.1MA$2.8MA$3.4MA$2.6MA$1.6M
Shareholders' equity
Common stock & paid-in capitalA$282.5MA$262.9MA$223.2MA$214.0MA$213.8MA$197.4MA$160.7MA$156.6MA$143.9MA$144.0M
Retained earnings (deficit)−A$245.6M−A$225.9M−A$214.2M−A$195.1M−A$181.9M−A$169.7M−A$151.0M−A$141.2M−A$129.6M−A$122.6M
Treasury stock———————A$0A$0A$0
Accumulated other comprehensive incomeA$5.8MA$5.3MA$4.8MA$4.0MA$3.6MA$2.8MA$866,121A$1.2MA$1.8MA$2.3M
Minority interest———————A$0A$0A$0
Total shareholders' equityA$42.7MA$42.4MA$13.8MA$22.8MA$35.5MA$30.5MA$10.5MA$16.6MA$16.1MA$23.7M
Key figures
Total debtA$193,475A$155,457A$159,045A$210,384A$117,489A$65,649A$33,747A$0A$0A$0
Net cash (debt)A$37.1MA$40.5MA$12.5MA$15.6MA$34.7MA$28.0MA$9.2MA$14.4MA$15.2MA$21.9M
Working capitalA$42.7MA$42.3MA$13.7MA$22.7MA$35.3MA$30.4MA$10.5MA$16.5MA$16.0MA$23.7M
Tangible book valueA$42.7MA$42.4MA$13.8MA$22.8MA$35.5MA$30.5MA$3.4MA$16.6MA$16.1MA$23.7M
Shares outstanding17.5M10.7M6.1M4.0M4.0M2.8M1.5M1.0M890K890K
Current ratio14.5212.983.546.177.0710.924.885.987.0615.88
Quick ratio14.2612.623.105.576.7810.513.415.796.9615.70
Debt / equity0.000.000.010.010.000.000.000.000.000.00
Equity / assets92.8%92.1%71.8%83.5%85.8%90.7%79.3%83.1%85.9%93.7%

Quarterly columns are labeled by the month the quarter ended. Figures in Australian dollars as reported (latest annual report filed August 28, 2026); data from EODHD.

ATHE financial position

At the end of fiscal 2026 (June 30, 2026), Alterity Therapeutics had total assets of A$46.0 million (down 0.0% from a year earlier), total liabilities of A$3.3 million and shareholders' equity of A$42.7 million. It held A$37.3 million in cash and short-term investments against A$0.2 million of debt, a net cash position of A$37.1 million. Its current ratio was 14.52.

Related: ATHE income statement, ATHE cash flow statement, ATHE key metrics. See the ATHE stock overview for the latest quote and news.

ATHE balance sheet FAQ

What are Alterity Therapeutics's total assets?

Alterity Therapeutics reported total assets of A$46.0 million at the end of fiscal 2026 (June 30, 2026), compared with A$46.0 million a year earlier.

How much debt does Alterity Therapeutics have?

Alterity Therapeutics had A$0.2 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.00.

How much cash does Alterity Therapeutics have?

Alterity Therapeutics held A$37.3 million in cash and short-term investments at the end of fiscal 2026; with A$0.2 million of debt that is net cash of A$37.1 million.

What is Alterity Therapeutics's book value?

Alterity Therapeutics's shareholders' equity (book value) was A$42.7 million at the end of fiscal 2026.

What is Alterity Therapeutics's current ratio?

Alterity Therapeutics had current assets of A$45.8 million and current liabilities of A$3.2 million, a current ratio of 14.52 (it can cover its short-term obligations).

Biotechnology: balance sheet